Corticosteroid effects on cell signalling Source: Eur Respir J 2006; 27: 413-426 Year: 2006
No associations of the mineralocorticoid and glucocorticoid receptor genes with asthma Source: Eur Respir J 2012; 40: 1572-1574 Year: 2012
TNFα-induced glucocorticoid resistance: Effect of steroidal and non-steroidal GR agonists, formoterol and inhibition of inflammatory signalling Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Association of adrenal response in asthmatic children on inhaled steroids with polymorphisms in the genes of glucocorticoid receptor (GR) and corticotropin releasing hormone receptor 1 (CRHR1) Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Effect of long-acting β2 adrenergic receptor agonists and glucocorticoids on extracellular matrix production Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001
PKA/cAMP-independent transactivation of glucocorticoid receptor by long acting β2 agonists Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006
New pharmacodynamic monitoring of corticosteroid action on glucocorticoid receptor activation in sputum macrophages Source: Eur Respir J 2005; 26: Suppl. 49, 369s Year: 2005
Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids Source: Eur Respir J, 50 (2) 1700670; 10.1183/13993003.00670-2017 Year: 2017
Bronchial thermoplasty may increase steroid sensitivity by upregulating the expression of the glucocorticoid receptor Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
Characterising the cardiovascular safety profile of inhaled muscarinic receptor antagonists Source: Eur Respir Monogr 2020; 88: 238-250 Year: 2020
Anti-inflammatory and immunomodulatory potential of Cys LT1 receptor antagonists (LTRA) in steroid dependent persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005
Influence of endorphins and opioid receptors antagonist N-acylstearoilethanolamine (NAE) on Th function in COPD after low dose radiation exposure Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006
Ligand independent activation of the glucocorticoid receptor by long acting β2 agonists Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
Increased doses of inhaled corticosteroids versus addition of long-acting beta2 agonists for treatment of asthma Source: Annual Congress 2010 - Treatment options for asthma Year: 2010
Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma? Source: Eur Respir J 2001; 17: 1059-1061 Year: 2001
First line anti-inflammatory treatment for asthma: inhaled steroid or leukotriene antagonist? Source: Eur Respir J 2002; 20: Suppl. 38, 93s Year: 2002
Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007
Inhaled corticosteroids and leukotriene receptor antagonists induce protection against adenosine 5‘monophosphate induced bronchospasm in a synergic fashion Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Glucocorticoid receptor-binding characteristics in severe asthma Source: Eur Respir J 2003; 21: 985-988 Year: 2003
Real-life use and impact of inhaled steroids (ICS) and leukotriene receptor antagonists (LTRA) monotherapy in children with asthma Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010